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ABSTRACT
Heroin trafficking and consumption has increased steadily over the past decade in Tanzania, but limited
information regarding HIV and drug abuse exists for the northwestern city of Mwanza. Our study
investigates the epidemiology of drug use, and HIV risk behaviors among drug users in Mwanza. Using a
combination of targeted sampling and participant referral, we recruited 480 participants between June and
August 2014. The sample was 92% male. Seventy-nine (16.4%) of participants reported injecting heroin,
while 434 (90.4%) reported smoking heroin. Housing and cohabitation status were the only
socioeconomic characteristics significantly associated with heroin injection. More than half of heroin
injectors left syringes in common locations, and half reported sharing needles. Other risk behaviors such
as lack of condom use during sex, and the use of illicit drugs during sex was widely reported as well.
Among the study sample, there was poor awareness of health risks posed by needle sharing and drug
abuse. Our results show that heroin abuse and HIV risk related behaviors are pressing problems that have
largely been ignored in Mwanza. Harm reduction programs are greatly warranted in Mwanza.
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INTRODUCTION
The dual epidemic of HIV and drug abuse is an emerging public health problem in Tanzania. It is well
established that the injection of drugs is associated with HIV acquisition. Specifically, several studies
conducted in Eastern Europe1, China2, South East Asia3 and Russia4 have demonstrated that injection
drug use is a key factor in the spread of HIV infections, including Tanzania.5–7 Some of the people who
inject drugs (PWID) engage in HIV risk-related behaviors, such as sharing syringes and other injection
equipment and having unprotected sex. These behaviors are potential routes of HIV infection
transmission within the injection drug use community, which can then spill over into the general
population8.
Data on heroin use in Tanzania and the associated HIV risk factors is largely focused on Dar es
Salaam and Zanzibar. Rumored reports of heroin use along trucking routes from Dar es Salaam outwards
to other towns north and south prompted an examination of heroin use in the far northwestern city of
Mwanza. In this study, we detail the epidemiology of drug use, heroin injection and its associated HIVrelated risk behaviors in Mwanza, the second largest city in the nation. To our knowledge, this is the first
study of its kind to be conducted in Mwanza or elsewhere in Northwest Tanzania.

Objectives
The main goals of this study are to:
1) Describe the socioeconomic characteristics and epidemiology of substance use in a sample of
people who use drugs in Mwanza, comparing how PWID differ from non-PWID.
2) Highlight HIV-related knowledge and risk behaviors of the subgroup of PWID, in this
sample, and determine if the risk behaviors are heterogeneous.
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Injection drug use as a risk factor for HIV
It has been shown repeatedly in studies, primarily outside of sub-Saharan Africa, that drug
injection use is a significant risk factor for HIV. HIV risk behaviors include the frequency of needle use,
number of partners with whom injection equipment has been shared, and frequency of needle and syringe
sharing, as well as sharing non-injection equipment such as cookers, filters and water.9,10,11 In the past
decade, the increase in the number of heroin users has fueled a rise in HIV infections among PWID in
Tanzania.12
In Tanzania, the prevalence of HIV among PWID is alarming, and can be explained by the risk
behaviors practiced by PWID. For instance, PWID in Dar es Salaam reported injecting 3 times a day5,13
with 41% reported sharing needles in the past 6 days14. This has resulted in a rise in HIV infections.
While HIV prevalence in the country is estimated at 5.1%15 , HIV among injectors is fourfold the national
rate: 28% among male injectors and 62% among female injectors 28%.16 The large difference between
male and female HIV rates among PWID may be attributed to high risk sexual behaviors among female
PWID who are frequently also sex workers. In Dar es Salaam, female heroin injectors are more likely to
be living on the streets and have more sex partners.17 The difference between non-PWID and PWID HIV
infections will destabilize the HIV epidemic in Tanzania and is the impetus for the establishment of harm
reduction services, such as methadone treatment, to reduce HIV transmissions in Dar es Salaam.
Further worsening the epidemic is a dangerous practice called “flashblood”, where a syringe of
blood is drawn from a person who just injected heroin and passed on to another as a proxy for drug
injection6,7. Dahoma et al.8 highlight that flashblood sustains a drug habit and concurrently catalyzes a
new subset of the HIV epidemic in Tanzania. The practice of flashblood underscores the complexity of
drug abuse and the HIV epidemic in Tanzania. It is important that this practice is acknowledged so that
the nuances of injection use can be addressed. Understanding the epidemiology of heroin injection and
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HIV-related risk behaviors will allow policymakers to implement targeted methadone and needle
exchange programs, along with HIV prevention and education programs.

Heroin abuse has become a major problem in Tanzania
In recent years, East Africa has become an important transit hub point for heroin in the
international drug trade for
traffickers

from

Afghanistan and Pakistan.
However, East Africa itself
has

also

become

a

consumer of heroin in the
process.18 The local market
is estimated to consume at
least 2.5 tons of pure heroin
per

year,

million.19
prevalence
Figure 1: Drug circulation within Tanzania and neighboring countries.
Mwanza lies on the shores of Lake Victoria by Rwanda, Uganda and Kenya
(Map modified from Grosskurth et al, 2000). Arrows indicated drug
transportation routes.

worth

$160

Given

the

of

HIV

and

other blood-borne diseases
in the region, attention must
be paid to heroin abuse.

Figure 1 describes the flow of drug shipment into and within Tanzania. Heroin is shipped to Dar
es Salaam from points in the Middle East and Southeast Asia. Heroin is then trafficked inland from Dar es
Salaam along major trucking routes – the northern route is through Arusha towards Mwanza. According to
policing reports supplied to the Tanzanian Drug Control Commission20, Mwanza is a strategic location for
drug traffickers to relay their goods across Lake Victoria to Uganda and via trucking routes to Kigali,
Rwanda.
7

Several studies have shown that drug use in sub-Saharan Africa may be more common than
anticipated,21 and that injection use is on the rise in Nigeria, South Africa and Kenya.22,23 Just as HIV
spread sexually along trading routes in East Africa, HIV is growing in areas where heroin is trafficked
and people begin to inject drugs. 24,25
There are no official figures on the number of PWID or illicit drug users in Tanzania. However,
there are an estimated 15,000 PWID living in Dar es Salaam, most of whom inject heroin.26 Based on the
growing prevalence of HIV among heroin injectors in Dar es Salaam, the Tanzanian government and the
US CDC requested Dr. Bruce in late 2009 to begin working towards starting methadone treatment in Dar
es Salaam as primary and secondary HIV prevention for PWID. In 2011, the first methadone clinic
opened at Muhimbili National Hospital in Dar es Salaam. This clinic was a cooperative with Yale
University, the Ministry of Health and Social Welfare, CDC/PEPFAR, Pangaea Global AIDS Foundation
and the Tanzanian Drug Control Commission. In 2012, the second clinic was established at
Mwananyamala with further expansion plans at Temeke and Illala sites.12
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Methadone Maintenance Treatment and Needle Exchange Program Efficacy
Evidence has suggested that harm-reduction programs are more effective than drug control
policies.27 In the United States, methadone maintenance treatment (MMT) has been proven to be safe and
effective as a treatment for drug addiction weaning drug users off opiates.28 MMTs have also been shown
to avoid HIV related risk behaviors.29,30 Trials have shown that methadone can reduce the use of heroin
among dependent people, and that methadone can be used to retain users in treatment programs.31 Those
who enroll in MMTs are also less likely to engage in HIV risk behaviors.32
The other alternative is the needle exchange programs (NEP), which provides clean syringes and
needles to PWID. It has been shown that NEPs are not associated with severe negative consequences,
which include increased illicit drug use and increased prevalence of other needle HIV risk related
behaviors.

33

In fact, NEPs reduce risk of HIV transmission without necessarily increasing drug use, and

increased enrollment in drug treatment.34,35 Even in resource-poor countries, it has been shown that HIV
increases by 5.9% in cities without NEPs, and decreases by 5.8% per year in cities with NEPs.36 Taken
together, these results suggest that MMTs and NEPs are effective in HIV risk behavior prevention and
increased incidence of HIV infections.

Mwanza as a Study Site
Although much is known about the epidemiology of HIV among PWIDs in Dar es Salaam, there
is a lack of PWID specific data in Mwanza. The seminal “Mwanza and Rakai Trials” conducted from
1991-1994 detailed community based HIV intervention focused on treatment of STIs37,38. The trials did
not detail HIV and HIV risk factors among PWIDs.
Until now, only a handful of studies have explored the relationship between drug use and HIV in
Mwanza. The most recent published works in Mwanza studied the role of biological, behavioral and
socio-demographic risk factors for HIV among young people in the Mwanza region39, the role of HIV
serostatus disclosure in Sekou-Toure hospital in Mwanza40 and factors associated with HIV status among
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some drug users in Mwanza.41 Although these studies provide the foundations for HIV studies conducted
in Mwanza, there is no component in these studies that detail HIV-related risk behaviors and associated
sociodemographic factors among PWID. To provide a targeted and effective intervention in Mwanza,
determining HIV-related risk factors and its associated sociodemographic factors is an important first
step. It is the long-term goal of this study to accelerate the implementation of formal, governmentsponsored methadone and needle exchange programs to be set up in Mwanza.
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METHODS
Field Work
From the June to August 2014, 480 subjects were recruited and interviewed about their drug abuse habits
and associated risk behaviors. Drug users were recruited based on a combination of targeted sampling and
participant referral42
A team of 3 people that comprised of a former drug user, an outreach worker and the primary
investigator conducted recruitment and the interviews. The former drug user has been drug-free for 8
years, and has built up an extensive rapport with the community. The outreach worker had been working
with the community for 4 years. The outreach workers had established trust with the community prior to
the start of the data collection period. Their knowledge and established trust with the drug using
community made data collection a relatively smooth process.
A sampling plan was developed using information gleaned from the interviewers who have
extensive experience working with illicit drug users in Mwanza. The interviewers for this study were
hired as both outreach workers and interviewers. This information was then used to target certain
neighborhoods in the city that were known as ‘hotspots’ for drug users. Neighborhood selection was then
confirmed by direct observation of drug use by the interviewers. In total, 12 study areas were selected and
50-60 people were interviewed per area. Study areas were determined according to ‘wards’ – local
administrative districts – and then further divided according to street names where drug users were
reported to congregate. We selected 7 wards, and out of these 7 wards, 12 streets. Data collection began
at the street closest to the primary investigator’s office, and ended in the area furthest away.
Study subjects were informed of the study prior to commencing the interview. Verbal informed
consent was obtained before conducting the interview. Interviews were conducted on-site, one participant
at a time. Interviews were conducted in Swahili.
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Eligible participants were those who self-reported to be above the age of 18, had injected drugs in
the past 12 months, or used any other kind of drug in the past 12 months. Many of those approached on
the streets typically were preparing to use illicit drugs. Screening measures for drug use included selfreport and visual inspection for injection marks on the arms, feet or legs. Illicit drug users were typically
found in groups in alleyways, in rented rooms, abandoned homes, or common congregation areas such as
football fields. Some participants also showed us their injection equipment and drugs as proof that they
were abusers. Participants who completed the interview were eligible to be given a small inexpensive
meal, drink and/or snack after the interview. On average, each meal cost 958 TSH (USD$0.50).
Data were collected in Swahili using a self-designed questionnaire based on instruments
employed by the World Health Organization (AUDIT survey), Tanzanian AIDS Prevention Program
(MAT Pilot Program Client Assessment form) as well as previous instruments based on alcohol abuse
that have yielded promising results.43 Responses that were unclear or inconsistent were verified among
members of the data collection team. The primary investigator provided regular feedback to the
interviewers daily as part of the data editing and cleaning process. Feedback was based on 3 key points:
completeness, accuracy, and consistency between answers. Open-ended questions were also reviewed
more closely to ensure that all responses were written legibly. After verification, written responses were
then translated back into English.
The study was reviewed and approved by the institutional review boards for the protection of
human subjects at Yale University, USA (HSC #1404013808) and at National Institute of Medical
Research (NIMR) in Tanzania.
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Instrument
Socioeconomic characteristics were measured by age, gender, education, marital status, living
arrangements, source of income and income levels.
Non-injection drug use was measured by asking participants if they had ever used marijuana,
pharmaceutical drugs, heroin/cocaine, followed by use in the past 12 months, and then current use.
Current use was defined as any use within the past week. Injection drug use was then measured by asking
participants if they had ever injected, followed by current injection. Drug use was also measured by
asking the participants the number of times drugs of any kind were used per day, followed by the number
of days drugs were used. Participants were also asked about the reasons they began using drugs, and when
they began using drugs.
Syringe-related risk was assessed by asking participants if they have ever shared syringes or
needles, if someone else had taken their needle, if they have shared injection equipment with other users,
and what materials were used to clean the needles and other injection equipment with. Two questions
about flashblood practices were also asked to assess the prevalence of flashblood practice among the
Mwanza drug user population.
Two open-ended questions that tested participants’ knowledge of health risks of using drugs and
sharing needles were asked. Open-ended questions were asked instead of offering participants multiple
choices, so as to assess the participants’ knowledge as accurately as possible.
Sexual risk was measured by asking if participants used any form of drugs and condoms during
sex, and the number of partners that they engaged in sexual intercourse with over the past 30 days. The
age of sexual debut was also determined.
Alcohol risk was measured by asking if participants had ever consumed alcohol, followed by
frequency of alcohol consumption and frequency of binge drinking, defined as having more than 6 drinks
on one occasion.
13

Statistical Analyses and Data Management
Data was entered into an OpenClinica (Waltham, MA) database and analyzed with the statistical
analysis software R (R Core Team, 2014). Data from all 480 participants were available for analysis. A
key outcome of interest was heroin injection, defined as either yes or no. We fitted two logistic models to
heroin injection use: socioeconomic characteristics, and HIV risk related behaviors.
Predictors measured at continuous integer levels were recoded into discrete categories that
reflected the distribution of data. Predictors measured as open-ended questions were recoded into nonordinal discrete categories. The reference category for each predictor was the one that had lowest
perceived HIV risk. Each predictor was individually correlated with likelihood of injection use. Predictors
with the highest level of correlation and significance (p<0.2) were included in the multivariate models.
Akaike Information Criterion (AIC) and deviance tests were used to compare models to one that included
all independent significant variables associated with injection use. The model with the lowest AIC value
was used as the final reduced model. Incomplete data were omitted from the model.
Predictors were analyzed for independence, i.e. if there was any interaction between the terms.
All predictors were found to be independent. Interaction terms were not included in the final model as
none were found to be significant.
Results are presented in the form of odds ratios with 95% confidence intervals. Significance of
odds ratios was assessed using 95% confidence intervals and chi-squared tests. We used chi-squared tests
to assess differences in socioeconomic characteristics and risk behaviors between PWID and non-PWID.
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RESULTS
Demographics
In our sample of 480 participants, we interviewed 442 males (92%) and 38 (8%) females. The
overall mean age of our study sample was 28.8 ± 6.3 years. The mean age among PWID was 29.0 ± 5.8
years, while the mean age among those who had never injected drugs was 28.3 ± 6.4 years. A majority of
the cohort had either completed primary school (30.4%) or had dropped out in lower secondary school
(Form 1-4) (35.6%). More than half of the cohort had never been married (61.0%), and a fifth (19.8%)
were divorced or separated. More than a tenth of the study population (10.4%) were living on the streets
or considered themselves homeless, where 170/480 (42.3%) rented rooms. A significant fraction (69.4%)
of the sample reported having a job as a primary source of income where slightly less than a third (27.7%)
reported stealing or pickpocketing as a primary source of income.

Epidemiology of Drug Use and HIV Related Risk Behaviors
Among our study population, 65/480 (13.5%) reported currently injecting drugs, and 79/480
(16.5%) reported a history of injection use. A majority of those who had ever injected drugs remained
injectors (82.3%). Almost everyone interviewed (99.4%) reported using drugs 7 days a week. Selfreported daily frequency of any kind of drug use ranged from once a day to a maximum of 25 times a day.
The most commonly reported frequencies were: 3 times a day (20.8%), 5 times (20.0%), and 4 times
(18.8%).
We found that many current injectors reported engaging in HIV-risk related injecting behaviors.
For example, 44/65 (66.7%) reported sharing needles, 31/65 (47.7%) shared injection equipment and
41/65 (63.1%) left syringes in public locations. Only 58/65 (89.2%) of the current injectors reported
cleaning injection equipment. Out of these, only 32.7% cleaned their equipment with bleach, while the
remainder (43.1%) used potable water, a noneffective method of sterilization.44
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We were next interested in exploring the relationship between socioeconomic status and type of
drug use. To assess socioeconomic status, we used the following measures: age, gender, education level,
marital status, living arrangement and income source. However, we found that these factors were not
significantly associated with heroin injection (summarized in Table 1A).
A majority of PWID were in the 21-25 (31.1%) and 26-30 (28.4%) age groups. Similarly for nonPWID, a majority were in the 21-25 (29.3%) and 26-30 (30.4%) age groups. More females were PWID
than not (12.7% vs. 7.0%, p>0.05). Fewer males were PWID than non-PWID (87.3% vs. 93.0%, p>0.05).
More PWID had never gone to school compared to non-PWID (6.3% vs. 3.5%, p>0.05. A greater
proportion of PWID reported some form of higher secondary education (8.9% vs. 6.7%, p>0.05) and
post-secondary education compared to non-PWID (10.1% vs. 5.0%, p>0.05). In terms of marital status,
more PWID were separated or divorced compared to non-PWID (27.7% vs. 18.0%, p>0.05). A smaller
proportion of PWID were married with one spouse compared to non-PWID (4.6% vs. 16.2%). More
PWID lived without a spouse/partner compared to non-PWID (88.6% vs. 81.9%). Those who were
separated or divorced were approximately 6 times (OR: 5.92; 95%: 1.91-26.02) more likely to inject
heroin compared to those who are married with one spouse.
Room rental was the most common living arrangement among both PWID (45.6% vs. 42.3%,
p>0.05). Living on the streets was slightly less prevalent among PWID than non-PWID (8.9% vs. 10.7%,
p>0.05). Income sources differed very little between PWID and non-PWID (p>0.05). More than half of
PWID and non-PWID have jobs as their main source of income (68.4% vs. 69.6%, p>0.05). Those who
had jobs mostly reported that they sold household items or were drivers.
Table 1B shows a profile of the self-reported drug use among the study population. Among the
types of drugs injected, heroin was the most commonly used (16.4%). Other reported injected drugs
comprised of methamphetamine, cocaine and pharmaceutical drugs that included Diclopa and Valium.
The most common non-injected type of drug used was marijuana (95.0%) and heroin (90.4%). Heroin is
commonly smoked with marijuana in joints called kokteli (translated to “cocktail”), as a large percentage
16

of users reported doing so (86.0%). Less commonly reported among the study population is the
combination of marijuana, non-injection heroin and pharmaceutical drugs (12.5%).
In addition to injecting heroin, smoking heroin was most commonly reported (83.0%) as a
concurrent behavior, followed by smoking marijuana (77.2%). Injectors often engaged in smoking
marijuana and heroin (63.3%) in addition to injecting. Injectors also reported engaging in smoking heroin,
marijuana and pharmaceutical drugs simultaneously (15.2%). These combinations of risky behaviors are
not independent of each other.

HIV-Related Risk Behaviors
We show in Table 2 that PWIDs have used drugs for a longer period of time compared to nonPWIDs (8.73 years vs. 7.78 years, p>0.05). The range of drug use among PWID extends from 0 – 20
years. Among non-PWID, the range extends from 0 – 33 years. People who are more likely to engage in
heroin injection are those who have been using drugs for a period of 11-15 years (29.2% vs. 18.8%) and
16-20 years (12.5% vs. 8.6%) compared to those who have been using for 0-5 years.
Those who have sold items for drugs are more likely to engage in heroin injection than other
routes of administration (88.6% vs. 66.3%, p<0.05). Similarly, those who have traded sex for drugs are
more likely to engage in heroin injection than not (36.9% vs. 14.0%, p>0.05). Those who have been
arrested by the law also were more likely to engage in heroin injection than not (97.5% vs. 83.4%,
p<0.05). Compared to non-PWID, PWID also typically reported having spouses/partners who are drug
users (13.9% vs. 7.5%, p>0.05). The reported use of any type of drugs during sex was comparable among
PWID and non-PWID (89.8% vs. 83.3%, p>0.05).
Peer pressure, defined as influence from members of his/her social circle, was one of the most
commonly cited reasons for starting drug use among PWID and non-PWID (79.7% vs. 80.0%). More
PWID cited family problems as the reason for starting drugs than non-PWID (5.1% vs. 2.5%, p>0.05).
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This further highlights the result in Table 5A where we found that housing status and co-habitation are
significantly associated with heroin injection.
We next examined whether injection drug users had different sexual practices than the noninjection users. Risky sexual behaviors were found to be different between PWID and non-PWID. More
non-PWID experienced sexual debut between the ages of 11-13 than PWID (43.1% vs. 40.3%, p>0.05).
More PWID than non-PWID reported having more than 5 sex partners in the past 30 days (12.7% vs.
7.9%, p>0.05). Overall, there was no significant difference between the number of sex partners among
PWID and non-PWID. The use of condoms all of the time was less common among PWID than nonPWID (6.3% vs. 13.0%, p>0.05). More PWID did not use condoms at any time than non-PWID (26.6%
vs. 22.8%, p>0.05).
In our sample, heroin injection and alcohol were not closely associated. Overall, risky alcohol
behaviors were not significantly different between PWID and non-PWID. More non-PWID reported
drinking 4 or more times a week than PWID (43.4% vs 37.0%). Similarly with binge drinking, more nonPWID reported binge drinking on a daily basis than PWID (20.1% vs. 4.3%).

HIV-related injection Risk Behaviors among Injectors
In Table 3, we highlight HIV-related injection risk behaviors among injectors. We found that many of
those with a history of heroin injection are still current PWID (82.2%). Among current PWID, 44/65
(67.7%) have ever shared needles. Approximately half of PWID (47.7%) in our sample reported having
shared injection equipment. A majority of the PWID (89.2%) reported cleaning their injection equipment
and needles using soap (6.2%), alcohol (9.2%), bleach (29.2%), boiling water (4.6%), and cold water
(38.5%).
The practice of flashblood was known among the study population, but rarely practiced. There
were 6 people in the study who had practiced flashblood. The frequency of flashblood use could not be
18

determined for all 6 users, as flashblood was only practiced when the users could not find heroin. The
ages of the flashblood users were 19, 30, 32, 34 and 38 years old, and one was unknown. All are current
heroin injection users, and all also use non-injection heroin. Only 2/6 users used marijuana. All of the
flashblood practitioners shared needles, shared injection equipment, have taken someone else’s syringe
and leave syringes in common locations. Two-thirds of users knew that one could contract HIV from
using needles. However, disturbingly, 5/6 people could not cite any type of health problems associated
with drug use. Two-thirds of users reported not using a condom the last time they had sex, and two-thirds
reported using heroin during sex frequently.
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Knowledge of risks posed by drug use and using needles
Knowledge and awareness about the risks posed by using and sharing needle is crucial to HIV prevention.
We explored this in Table 4A and 4B by and showed that approximately one third (32.3%) of the study
population did not know about any kind of health risk posed by sharing needles. However, more than half
the study population (64.6%) was aware that HIV was a risk posed by sharing needles, where fewer knew
that sharing needles could lead to hepatitis C (26.2%), and TB (15.4%). Not knowing about the risks of
using and sharing needles was associated with more than 4 times the odds of injecting heroin compared to
those who are aware of some risks.
More than half the study population was not aware of the general health problems associated with
drug use. One-fifth (20.6%) was aware that drug abuse could cause TB, loss of memory (16.3%),
dehydration (8.8%) and loss of appetite (4.2%).
After adjusting for knowledge of other diseases, the adjusted multivariate model demonstrated
that “not knowing” and knowledge of TB were the two main knowledge factors associated with heroin
injection. The odds of injection drug use among those who were not aware of any problems is 10.4 times
(95% CI: 5.88 – 18.97) that of those who do know.

Factors Associated with Heroin Injection
To find the strongest predictors for heroin injection, we conducted factor analysis. Factor analysis
removes redundancy from a set of correlated variables, such that the final model is one that contains the
most highly correlated predictors. The reduced multivariate model in Table 5A demonstrated that housing
and co-habitation status were the strongest socioeconomic predictors of injection drug use out of all the
other variables. PWID are also twice as likely to rent a house than own a house (OR: 2.62; 95%CI: 0.7210.17). Further, those who rent a room in a guesthouse are 2.28 times (95% CI: 0.56 – 9.64) as likely to
inject heroin as those who own a house. Those who have a free room at a friend’s or relative’s house are
0.32 times (95% CI: 0.24 – 2.26) less likely to inject heroin than those who own a house. Those who live
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on the streets are also 0.26 times (95% CI: 0.21 – 2.81) less likely to inject heroin than those who own a
house. The odds of heroin injection among those who do not live with a spouse are 2.25 times (95% CI:
1.05 – 5.44) that of those who do live with a spouse.
Further, as shown in Table 5B, multivariate analysis demonstrated that years of drug use, selling
items for drugs, trading sex for drugs and being arrested by law enforcers are strongly associated with
injection drug use. The odds of injection drug use among those who have used drugs for 11-15 years and
16-20 are 1.09 times (95% CI: 1.00 – 1.18; 0.96-1.22) compared to those who have used drugs for 0-5
years. Those who reported selling items for drugs are 1.12 times as likely to inject heroin compared to
those who have not. Similarly, those who have traded sex for drugs are 1.22 times significantly as likely
to inject heroin compared to those who have not. The importance of these HIV-related risk behaviors in
predicting heroin injection cannot be discounted.
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TABLE 1A: Socioeconomic Characteristics and Relationship between Current and
No History of Injection

Age (+s.d.)

Ever* Heroin
Injection (%)
n =79

Never Heroin
Injection (%)
n = 401

Unadjusted Odds
ratio of Heroin
Injection (95% CI)

P-value for
independence*

29.0 ± 5.8

28.3 ± 6.4

0.98 (0.94 – 1.02)

0.52

Age

0.38

<20

4 (5.4)

19 (4.9)

1.51 (0.41 - 4.62)

21-25

23 (31.1)

114 (29.3)

1.37 (0.70 – 2.75)

26-30

21(28.4)

118 (30.4)

1.00

31-35

18(24.3)

81 (20.9)

1.18 (0.55 – 2.52)

>36

8 (10.8)

56 (14.4)

0.48 (0.13 – 1.36)

Gender

0.14

Male

69 (87.3)

373 (93.0)

0.47 (0.22 – 1.09)

Female

10 (12.7)

28 (7.0)

1.00

Education Level

0.21

Never went to school

5 (6.3)

14 (3.5)

1.23 (0.27 – 5.38)

Incomplete primary

9 (11.4)

73 (18.2)

0.50 (0.15 – 1.78)

Completed primary

22 (27.8)

124 (30.9)

0.65 (0.23 – 2.11)

Secondary (Form 1-4)

28(35.4)

143 (35.7)

0.71 (0.26 – 2.29)

Secondary (Form 5-6)

7 (8.9)

27 (6.7)

1.19 (0.34 – 4.50)

Post Secondary

8 (10.1)

20 (5.0)

1.00

Marital Status

0.10

Single/never married

47 (64.6)

246 (61.3)

4.23 (1.49 – 17.8)

Married or living as
married (1 spouse)

7 (4.6)

65 (16.2)

1.00

Married or living as
married (>1 spouse)

2 (3.7)

11 (2.7)

4.61 (0.56 – 30.9)

Separated/divorced

23 (27.7)

72 (18.0)

5.92 (1.91 – 26.02)

Widowed

0 (0.0)

7 (1.7)

-
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Housing Status

0.22

Own house

5 (6.3)

32 (8.0)

1.00

Rented house

7 (8.9)

19 (4.7)

3.50 (0.83 – 18.0)

Renting room in
guesthouse

6 (7.6)

12 (3.0)

5.83 (1.33 – 31.2)

Renting room
elsewhere

36 (45.6)

170 (42.3)

1.76 (0.58 – 7.65)

Free room at friends
or relative’s house

18 (22.7)

124 (30.9)

1.48 (0.46 – 6.62)

7 (8.9)

43 (10.7)

1.90 (0.49 – 9.31)

On the Streets
Living with
husband/wife

0.19

Yes

9 (11.4)

72 (18.1)

1.00

No

70 (88.6)

325 (81.9)

2.72 (1.16 – 7.99)

Income Source

0.94

Family/friends

2 (2.5)

11 (2.8)

0.78 (0.44 – 1.39)

Job

54 (68.4)

279 (69.6)

1.00

Illicit activities

23 (29.1)

110 (27.4)

0.98 (0.14 – 3.99)

* Ever injection was used as the primary variable, but it must be noted that the majority of the ever
injectors were also current injectors (82%).

** T-test for continuous variables, chi-square test for categorical variables
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TABLE 1B: Profile of Self-Reported Drug use among the Study Population
Type of Drug Injected

N (%)

Heroin

79/480 (16.4)

Methamphetamine

2/480 (0.4)

Cocaine

2/480 (0.4)

Pharmaceuticals

3/480 (0.6)

Type of Drugs Not-injected
Marijuana

456/480 (95.0)

Non-injection heroin

434/480 (90.4)

Pharmaceutical

71/480 (14.8)

Hash

13/480 (2.7)

Solvent

17/480 (3.5)

Marijuana and Non-Injection Heroin

413/480 (86.0)

Marijuana and Non-Injection Heroin and
Pharmaceutical

60/480 (12.5)

Combined Heroin Injection + Non-injected
Drugs
Injection Heroin + Marijuana

61/79 (77.2)

Injection Heroin + Non-Injection Heroin

66/79 (83.5)

Injection Heroin + Non-injection
Pharmaceuticals

20/79 (25.3)

Injection Heroin + Hashish

2/79 (2.5)

Injection Heroin + Solvent

10/79 (12.7)

Injection Heroin + Marijuana and noninjection heroin

50/79 (63.3)

Injection Heroin + Marijuana and Noninjection Heroin and Pharmaceutical

12/79 (15.2)
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TABLE 2: Selected Unadjusted Associations between Risk Behaviors and Heroin
Injection
Ever Injection
Drug Use
(n=79)

Never
Injection Drug
Use

Unadjusted Odds ratio
of injection drug use

p-value of
independence

1.03 (0.98 – 1.07)

0.15

(n = 401)
Years since first use
(+ s.d.)

8.73 ± 5.1

7.78 ± 5.9

Years since first use

0.16

0 – 5 years

26 (36.1)

153 (41.1)

1.00

6 – 10 years

16 (29.8)

111 (29.8)

0.93 (0.47 – 1.78)

11 – 15 years

21 (29.2)

70 (18.8)

1.94 (1.02 – 3.63)

16 – 20 years

9 (12.5)

32 (8.6)

1.81 (0.75 – 4.10)

Ever sold items for
drugs

<0.05

Yes

70 (88.6)

265 (66.3)

3.96 (2.02 – 8.73)

No

9 (11.3)

135 (33.8)

1.00

Traded sex for drugs

<0.05

Yes

29 (36.9)

56 (14.0)

3.55 (2.06– 6.07)

No

50 (63.0)

343 (85.9)

1.00

Arrested by law
enforcers

<0.05

Yes

77 (97.5)

333 (83.4)

7.75 (2.36 – 47.8)

No

2 (2.5)

67 (16.8)

1.00

Spouse/partner is a
drug user

0.09

Yes

11 (13.9)

30 (7.5)

1.98 (0.92 – 4.06)

No

66 (83.5)

363 (90.9)

1.00

Don’t know

2 (2.5)

6 (1.5)

-

Use of drugs during
sex

0.18
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Yes

71 (89.8)

333 (83.3)

1.78 (0.87 – 4.18)

No

8 (10.1)

67 (16.8)

1.00

Main reason for
starting drugs

0.10

Peer pressure

63 (79.7)

320 (80.0)

-

For fun

3 (3.8)

9 (2.3)

-

Family problems

4 (5.1)

10 (2.5)

-

Influence from family

3 (3.8)

17 (4.3)

-

Other

4 (5.1)

11 (2.8)

-

Age of sexual debut

0.84

11 – 13

27 (40.3)

150 (43.1)

1.19 (0.48 – 3.16)

14 – 17

32 (47.8)

155 (44.5)

0.99 (0.48 – 2.41)

18+

8 (11.9)

43 (12.3)

1.00

Number of sex
partners in the past 30
days

0.10

None

16 (20.2)

104 (27.1)

1.00

1

25 (31.6)

135 (33.6)

1.20 (0.62 – 2.41)

2-5

21 (26.6)

115 (28.7)

1.19 (0.59 – 2.43)

>5

10 (12.7)

32 (7.9)

2.03 (0.81 – 4.87)

Use of condoms
during vaginal sex

0.08

None of the time

21 (26.6)

91 (22.8)

1.66 (0.86 – 3.21)

Some of the time

29 (36.7)

98 (24.5)

2.13 (1.16 – 3.96)

Most of the time

7 (8.9)

52 (13.0)

0.97 (0.37 – 2.31)

All the time

5 (6.3)

52 (13.0)

1.00

Alcohol consumption

0.37

Monthly or less

5 (10.9)

21 (9.5)

1.00

2-4 times a month

9 (19.6)

53 (24.2)

0.71 (0.23 – 2.55)

2-3 times a week

15 (32.6)

50 (22.8)

1.26 (0.43 – 4.27)
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4 or more times a
week

17 (37.0)

95 (43.4)

0.75 (0.26 – 2.49)

Binge drinking
frequency

<0.05

Never

26 (56.5)

115 (52.5)

1.00

Less than monthly

7 (15.2)

21 (9.6)

1.32 (0.48 – 3.29)

Monthly

5 (10.9)

17 (7.8)

1.16 (0.36 – 3.24)

Weekly

3 (6.5)

22 (10.0)

0.54 (0.12 – 1.70)

Daily

2 (4.3)

44 (20.1)

0.18 (0.02 – 0.63)

TABLE 3: HIV-related injection Risk Behaviors among Injectors
Current Heroin Injection drug use

65/79 (82.2%)

Ever shared needles

44/65 (67.7%)

Leave syringes in common locations

41/65 (63.1%)

Share injection equipment

31/65 (47.7%)

Clean injection equipment

58/65 (89.2%)

Soap

4/65 (6.2%)

Alcohol

6/65 (9.2%)

Bleach

19/65 (29.2%)

Boiling Water

3/65(4.6%)

Cold Water

25/65 (38.5%)

Flashblood practice

6/79 (7.6%)
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TABLE 4A: Selected unadjusted and adjusted associations between awareness of
risks posed by using and sharing needles and injection drug use
Awareness of risks
posed by sharing
needles

PWID (Heroin)

Unadjusted odds
ratio of injection
drug use

Adjusted odds ratio of
injection drug use

Don’t know about
risks

21/65 (32.3%)

6.87 (3.94 – 12.32)

4.55 (2.48 – 8.30)

HIV

42/65 (64.6%)

6.41(3.70 – 11.36)

-

Hepatitis C

17/65 (26.2%)

6.24 (3.13 – 12.32)

2.84 (1.32 – 6.18)

TB

10/65 (15.4%)

13.18 (4.39 – 44.21)

3.87 (1.16 – 15.21)

Mental problems

3/65 (4.6%)

9.99 (1.63 – 76.99)

-

Addiction

0/65 (0.0%)

-

-

Tumor

1/65 (1.5%)

-

-

Loss of appetite

0/65 (0.0%)

-

-

Heart disease

1/65 (1.5%)

-

-

(n=65)
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TABLE 4B: Selected unadjusted and adjusted associations between awareness of
risks posed by using any sort of illicit drugs
Health problems
caused by any sort of
illicit drugs

Total
population

Injection
Drug Users

Unadjusted odds
ratio of heroin
injection

Adjusted odds
ratio of heroin
injection

Don’t know

292 (60.8%)

34/65
(52.3%)

1.50 (0.88 – 2.53)

10.43 (5.88 –
18.97)

TB

99 (20.6%)

12/65
(18.5%)

0.85 (0.42 – 1.62)

0.37 (0.19 –
0.72)

Loss of memory

78 (16.3%)

13/65
(20.0%)

1.35 (0.67 – 2.55)

-

Dehydration

42 (8.8%)

12/65 (18.5)

2.91 (1.36 – 5.90)

-

Loss of appetite

20 (4.2%)

3/65 (4.6%)

1.13 (0.26 – 3.50)

-

Addiction

16 (3.3%)

0/65 (0.0%)

-

-

Cancer / tumor

11 (2.3%)

2/65 (3.1%)

Neurological damage

7 (1.5%)

4/65 (6.2%)

-

-

“Blood disease”

6 (1.3%)

5/65 (7.8%)

-

-

HIV

2 (0.4%)

1/65 (1.5%)

-

-

-
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TABLE 5A: Reduced model of Socioeconomic Characteristics and Injection Drug
Use
Socioeconomic Characteristics

Odds ratio of injection drug use P-value

Housing Status
Own house

1.00

-

Rented house

2.62 (0.72 – 10.17)

0.15

Renting room in guesthouse

2.28 (0.56 – 9.64)

0.25

Renting room elsewhere

1.12 (0.32 - 3.52)

0.82

Free room at friends or relative’s house

0.68 (0.24 – 2.26)

0.49

On the Streets

0.74 (0.21 – 2.81)

0.65

Yes

1.00

-

No

2.27 (1.05 – 5.44)

0.04

Living with husband/wife
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TABLE 5B: Reduced model of HIV related risk behaviors and injection drug use
Odds ratio of injection drug
use

P-value

0 – 5 years

1.00

-

6 – 10 years

0.96 (0.89 – 1.04)

0.36

11 – 15 years

1.09 (1.00 – 1.18)

0.06

16 – 20 years

1.09 (0.96 – 1.22)

0.17

Yes

1.12 (1.04 – 1.21)

<0.05

No

1.00

-

Yes

1.22 (1.12 – 1.33)

<0.05

No

1.00

-

Yes

1.11 (1.00 – 1.22)

<0.05

No

1.00

-

Years since first use

Ever sold items for drugs

Traded sex for drugs

Arrested by law enforcers
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DISCUSSION
To our knowledge, this is the first study to describe the epidemiology of drug use in general and injection
drug use in particular associated HIV related risk behaviors in Mwanza, Tanzania. Using a survey of 480
drug users, we show that a very high percentage of our sample population engaged in heroin use, and that
HIV risk behaviors were highly prevalent amongst current drug users in Mwanza. We also show that
there is only a marginal difference between PWID and non-PWID in terms of socioeconomic status.
These results suggest that the drug user population is heterogeneous and not confined to any one
particular socioeconomic stratum.
Prevalence of self-reported heroin use among the study population was extremely high (90.4%)
with an even higher prevalence of marijuana use (95.0%). Approximately a fifth of the study population
(16.7%) had a history of heroin injection drug use, and 13.5% were current heroin injection drug users.
An overwhelming majority of ever injectors are current injectors, which highlights the need for
rehabilitation programs as PWID are not receiving the treatment they need. Many users on the streets
were eager to be interviewed, as they were told that this research would help to enable a shift in
government policy towards drug users.
Very few people reported injection other types of drugs besides heroin. Combinations of smoking
heroin and marijuana were also commonly reported. This is not surprising given that both marijuana and
heroin are readily accessible. In particular, our study participants reported that approximately 0.5g of
heroin costs only 2000TSH (USD$1.10), and that 600g of marijuana cost 1000TSH (USD$0.55). Similar
figures were reported a decade ago.5 With such accessible prices, it is not surprising that heroin use has
become so rampant. It is also worrying that drug users who smoke heroin with marijuana may increase
the probability of transitioning to injection drugs. The median transition time from smoking to injection is
5 years, and for those under 25, it takes 2 years.45 These statistics, coupled with a high study participation
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rate within a short span of time, highlight that heroin abuse in Mwanza is a problem with a potential to
worsen, and reveals a hidden problem that is presently being ignored.6,46,47
The lack of significant socioeconomic characteristic differences between PWID and non-PWID is
not surprising. Previous studies in OECD countries had shown that high risk injection behaviors were not
related to socioeconomic markers,48 even among injectors who had experienced non-fatal overdoses.49
Our data show that being single, having a primary level or lower secondary level of education, and being
male were not significantly associated with heroin injection. This underscores the need for drug
prevention efforts that are aimed at users from various socioeconomic backgrounds in Mwanza, moving
away from the traditional “target risk group” behavior as Ratliff et al. suggest.12 These results highlight
the importance of home stability and family as a protective factor against heroin injection.
Between genders, because our sample comprised of mostly males, we were unable to determine if
risk behaviors between male and female PWID were heterogeneous. However, previous studies have
shown that male and female PWID exhibit different HIV-related risk behaviors. For instance, women tend
to have more sex partners and men tend to share needles and lend used needles to other injectors.17
Housing and cohabitation status were found to be the most significantly associated with injection
drug use in our multivariate model. Our data suggests that PWID are more likely to rent houses or rooms
than to own homes. We also found that PWID are more likely to not have a spouse or co-habiting partner
compared to non-PWID. This result suggests that home and family stability are closely associated with
injection drug use. Other heroin injection and HIV risk studies conducted outside of sub-Saharan
Africa50,51 have shown that housing status and residence are key factors in increased HIV risk and
injection drug use. Unstable housing was shown to be independently associated with several HIV risk
behaviors including borrowed needles, and suggest comprehensive housing policies be implemented.50 In
a similar vein, our results suggest for strengthening family ties through counseling. One of the first signs
of recovery is when the patient re-connects with family and is accepted back into the family.20
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Our results show that participants reported abusing drugs from as far back as 20 years ago. This is
not surprising. By the year 2000, there were two reported forms of heroin in circulation—brown and
white heroin.5 However, there has not been widespread reporting of drug abuse in the region until prior to
the mid-2000s. Narco-trafficking and substance abuse was more commonly reported in West Africa
compared to East Africa.52
Deciphering the start of the heroin epidemic is difficult. The type of drug that was first used was
not specified. Among our study participants, the mean length of drug abuse is 7.9 years. The most
common year that people began to use drugs was in 2006, implying a recent uptick in heroin imports in
the region. This is also consistent with UNODC reports that cite an increase in heroin seizures over the
past decade, which also imply that there could be many more undetected shipments.53 Our data shows that
heroin abuse is not a recent problem, but one that has remained invisible for many years. Similar to what
has been shown in other PWID studies45, our data show that the longer the length of drug use, the more
likely heroin injection becomes. If action is not taken to curb the critical period between heroin smoking
and injection, the drug abuse problem and consequently the HIV epidemic could be exacerbated gravely.
In Russia, 75% of all HIV cases occur among PWID, highlighting the urgent need for action to be taken
immediately.54
Risk behaviors that are significantly associated with heroin injection include: selling items for
drugs, trading sex, and being arrested. These are known risk behaviors that are associated with an
increased risk of heroin injection and HIV, as shown in previous studies in Dar es Salaam.5,7 Among our
study population, age of sexual debut, use of drugs during sex, condom use and number of sex partners
were not found to be significantly associated with heroin injection. However, it must be highlighted that
among our study population, some users have been having sex since age 11. Reported frequent condom
use during vaginal sex was also very low. A further sobering fact is that an overwhelming majority of
PWID and non-PWID alike began using drugs because of peer pressure. In rural Tanzania, it has been
shown in recent years that adolescent sexual health intervention programs are effective.55 Our results
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emphasize the need for scaled-up sexual education and HIV prevention among children starting in
primary school.
Our data show that alcohol risk behaviors are not significantly associated with heroin injection
While it is known that alcohol consumption is implicated in the spread of HIV/AIDS,9 our results show
that daily binge drinkers are significantly less likely to engage in heroin injection compared to those who
do not binge drink at all. Alcohol abuse in Tanzania is a growing problem in itself, which must not go
unheeded.41,43,56
Needle-related risk behaviors were widely reported among PWID. More than half the PWID
leave syringes in common locations and half the PWID shared injection equipment. The general
availability of syringes—which consists of a 2ml syringe and 23 gauge needle and is sold in a pack5—
facilitates needle-related risk behaviors. This increases the probability of HIV transmission among PWID
and is a concerning statistic. Taken with the fact that PWID are twice as likely to have sex with more
than 5 partners, our data suggest that heroin injection in Mwanza is a serious issue that could result in
further HIV spread.
Despite the widespread sharing of injection equipment, cleaning injection equipment was widely
reported among PWID. The most commonly used cleaning agent is cold water. Ideally, PWID should
clean their needles with bleach adequately to kill viruses, which is currently only being practiced by
29.2% of the PWID in our study population. Community-based outreach organizations should continue to
encourage cleaning with bleach in addition to reducing multi-person use of needles.
We investigated the prevalence of flashblood, as it has been widely reported in Dar es
Salaam.7,8,47 We found that although flashblood was not a significant concern among our study
population, it is worrisome that the practice was not unheard of and had been practiced. Among the 6
PWID with a history of flashblood, flashblood was only used when circumstances were dire i.e. when
both money and heroin was unavailable. This practice is not found anywhere else except for East Africa.
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As such, flashblood practice still should not be ignored, as it is a very dangerous and efficient vehicle for
the transmission of HIV/AIDS and other blood-borne diseases.
Prior to investigating awareness of needle risks, we asked more broadly if participants were
aware of health problems caused by any sort of general drug use. Awareness was poor. More than half the
study population could not cite a problem caused by general drug use. Approximately a fifth of the study
population cited TB as a risk, followed by memory and appetite loss and dehydration.
In Mwanza, awareness about health risks posed by using and sharing needles is poor. A third of
PWID were not able to list any health risks posed by using and sharing needles. Hearteningly, more than
half were able to report that contracting HIV/AIDS was a potential risk of needle sharing. Previous
prevention efforts conducted in the Mbeya region of Tanzania have shown that information, education
and communication about HIV is integral to the reduction of HIV prevalence.57 However, information
dissemination is only one part of the structural approach to HIV prevention; political support,
involvement, institutional participation and surveillance are key features of successful programs for
behavioral change in East Africa.57,58 In agreement with these findings, our data suggests that knowledge
alone is not enough as a prevention tool. For example, those who are aware about HIV, hepatitis C and
TB are actually more likely to engage in heroin injection than those who are not. This suggests that it is
not adequate to only raise awareness about diseases as a method of HIV prevention, and, as previously
mentioned, other forms of prevention such as methadone treatment and detoxification rehabilitation must
also be proactively considered by the government.

Contribution of Study
The results of this study should be used to catalyze the implementation of methadone clinics in
Mwanza and cities beyond Dar es Salaam and Zanzibar. Our results have highlighted that there is a
sizable population of heroin drug users in Mwanza, and that many PWID are engaging in high-risk
behaviors. However, we must not exclude the non-PWID as well. Given the large number of non-PWID
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who use heroin in our study sample, there is a high chance that non-PWID will make the transition to
injection later on in life. Research has shown that non-PWID exposed to treatment such as methadone
maintenance and rehabilitation are less likely to initiate injection.59

Study Limitations
Our study has several limitations. Firstly, although great care was taken to ensure that we had a
sizable and diverse sample of drug users, obtaining a random representative sample of hidden population
is extremely difficult. We were also not able to recruit many female drug users, which may have skewed
results. The nature of our study is also heavily reliant on self-report, which may have resulted in
underreporting of risky behaviors. However, self-report was and is still the main measure of risky
behavior.60 Further, our data are cross-sectional in nature, thus it is not possible to extrapolate the data to
make causal inferences. Finally, our data did not plot the chronological transition of users from using
non-injection to injection heroin. This would have allowed us to find a suitable intervention point among
drug users. Finally, future studies should include exploring the relationship between HIV serostatus,
heroin injection and sociodemographic status.
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Conclusion
The results of this study highlight that heroin abuse is a significant problem in a city outside Dar
es Salaam and Zanzibar, suggesting that Mwanza has now become a consumer hub of heroin, and may be
a transit hub for heroin to other parts of East Africa. We find that housing status and living arrangements
are the strongest predictors of heroin injection, and that many users began using drugs due to peer
pressure, underscoring the fact that family stability and home life should be taken into consideration in
HIV and drug prevention efforts in Tanzania. Many PWID were also reported to engage in needle sharing
and reported improper methods of cleaning needles. A significant proportion of the study population
exhibited a lack of awareness of the risks involved in needle sharing and drug abuse. However, even
among those who are knowledgeable about risks, the odds of heroin injection are high. This suggests that
HIV prevention must extend beyond education campaigns, such as ensuring that students stay in schools,
engaging in productive after school activities and encouraging family counseling. Failing to recognize
heroin injection abuse in Mwanza may derail the work that has been done to stabilize the epidemic in
Tanzania.
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